Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
55m
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
In an investor update on Tuesday, Amgen Inc (NASDAQ:AMGN) released data from Phase 3 trials of rocatinlimab and Uplizna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene now hurricane
Would-be assassin charged
Penn suspends law professor
Woman dies in 'suicide pod’
Campaign office damaged
US to waive visas for Qatar
Calls strike against 'LoL’
Texas AG appeal denied
InfoWars to be auctioned off
Briefed on Iranian threats
Exec apologizes for outage
Study: Myopia on the rise
School book bans surge
China conducts ICBM test
Chemical leak in OH county
Fat Bear Week coming up
First transparency report
To cut Atlanta service, jobs
Israel intercepts first missile
CA new gun control laws
New COVID, flu shots
Pac-12 sues Mountain West
NYC schools boss retiring
Union gets more voting time
Gets 2-yrs for role in fraud
Rioter mistakenly released
$375M military aid to UKR
New home sales fall
Feedback